{"date":"2025-11-01","count":1,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-7860-2025-11-01-0854-ka977s","company_id":"7860","company":"得生製藥","market":"興櫃","industry":"生技醫療","date":"2025-11-01","time":"08:54:26","subject":"公告本公司董事會決議召開114年第二次股東臨時會(更正主旨)","clause":"第32款","fact_date":"2025-10-31","cite_as":"公開資訊觀測站重大訊息：得生製藥（7860），2025-11-01 08:54，「公告本公司董事會決議召開114年第二次股東臨時會(更正主旨)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}